Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | NT5E | P21589 | 1/20 | 0.51 |
| ▸ | TACR2 | P21452 | 3/20 | 0.48 |
| ▸ | GJB2 | P29033 | 1/20 | 0.47 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.47 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.47 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.47 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.47 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.46 |
| ▸ | CDC25B | P30305 | 6/20 | 0.46 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.46 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2562480 | 1.00 | HTR1A (0.52) | HTR1ANT5ETACR2GJB2SSTR1 | |
| SCHEMBL14747295 | 1.00 | HTR1A (0.52) | HTR1ANT5ETACR2GJB2SSTR1 | |
| SCHEMBL1562064 | 1.00 | HTR1A (0.52) | HTR1ANT5ETACR2GJB2SSTR1 | |
| SCHEMBL19745164 | 1.00 | HTR1A (0.52) | HTR1ANT5ETACR2GJB2SSTR1 | |
| SCHEMBL16727960 | 1.00 | HTR1A (0.52) | HTR1ANT5ETACR2GJB2SSTR1 | |
| SCHEMBL12896357 | 1.00 | HTR1A (0.52) | HTR1ANT5ETACR2GJB2SSTR1 | |
| SCHEMBL1561335 | 1.00 | HTR1A (0.52) | HTR1ANT5ETACR2GJB2SSTR1 | |
| SCHEMBL5027926 | 1.00 | HTR1A (0.52) | HTR1ANT5ETACR2GJB2SSTR1 | |
| SCHEMBL1562065 | 1.00 | HTR1A (0.52) | HTR1ANT5ETACR2GJB2SSTR1 | |
| SCHEMBL20223437 | 1.00 | HTR1A (0.52) | HTR1ANT5ETACR2GJB2SSTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8278436-B2 | Glycosylated warfarin analogs and uses thereof | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-10-02 | — | — | US | claimed |
| US-20100267655-A1 | Glycosylated Warfarin Analogs and Uses Thereof | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-10-21 | — | — | US | claimed |
| WO-2010014814-A2 | GLYCOSYLATED WARFARIN ANALOGS AND USES THEREOF | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2010-02-04 | — | — | WO | claimed |
| US-20260042867-A1 | ANTIBODY REPURPOSING | SRI INTERNATIONAL (US) | 2026-02-12 | — | — | US | disclosed |
| EP-4591935-A2 | METHODS FOR THE PREPARATION OF RIBOSIDES | Gilead Sciences, Inc. (US) | 2025-07-30 | — | — | EP | disclosed |
| EP-4588928-A2 | METHODS FOR TREATING FILOVIRIDAE VIRUS INFECTIONS | Gilead Sciences, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| CN-113549120-B | Method for preparing ribonucleoside | 吉利德科学公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-108348526-B | Methods of treating arenaviridae and coronaviridae viral infections | 吉利德科学公司 | 2025-04-25 | — | — | CN | disclosed |
| EP-4036099-B1 | METHODS FOR THE PREPARATION OF RIBOSIDES | GILEAD SCIENCES INC (US) | 2025-03-19 | — | — | EP | disclosed |
| US-20240409575-A1 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | GILEAD SCIENCES, INC. | 2024-12-12 | — | — | US | disclosed |
| CN-118994170-A | Process for preparing 1' -cyanonucleosides | 吉利德科学公司 | 2024-11-22 | — | — | CN | disclosed |
| US-20080300200-A1 | Therapeutic Furopyrimidines and Thienopyrimidines | BIOCRYST PHARMACEUTICALS, INC. (US) | 2008-12-04 | — | — | US | disclosed |
| US-7429571-B2 | Therapeutic furopyrimidines and thienopyrimidines | BIOCRYST PHARMACEUTICALS, INC. (US) | 2008-09-30 | — | — | US | disclosed |
| EP-1970445-A1 | METHOD FOR NUCLEIC ACID REPLICATION AND NOVEL ARTIFICIAL BASE PAIRS | Riken (JP) | 2008-09-17 | — | — | EP | disclosed |
| US-20080171787-A1 | COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2008-07-17 | — | — | US | disclosed |
| US-20070185063-A1 | Seven-membered ring nucleosides | IDENIX PHARMACEUTICALS, INC. | 2007-08-09 | — | — | US | disclosed |
| EP-1397376-B1 | METHOD FOR PRODUCING PERBENZYLATED 1-O-GLYCOSIDES | SCHERING AG (DE) | 2005-05-04 | — | — | EP | disclosed |
| EP-1261614-B1 | METHOD FOR THE PRODUCTION OF PERBENZYLATED 1-O GLYCOSIDES | SCHERING AG (DE) | 2004-01-07 | — | — | EP | disclosed |
| US-6545135-B2 | Alkylation | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-04-08 | — | — | US | disclosed |
| US-20020002274-A1 | Process for the production of perbenzylated 1-0-glycosides | SCHERING AKTIENGESELLSCHAFT | 2002-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171787-A1 | COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE | TUBB6, TUBB, TUBA1C | HTR1A 4715/4885NT5E 788/4885TACR2 2051/4885 |
| US-20240409575-A1 | METHODS OF PREPARING 1'-CYANO NUCLEOSIDES | PNP, TYMP, DUT | HTR1A 1323/4885NT5E 69/4885TACR2 2790/4885 |
| US-20080300200-A1 | Therapeutic Furopyrimidines and Thienopyrimidines | DPYD, TYMP, TYMS | HTR1A 4285/4885NT5E 170/4885TACR2 4788/4885 |
| US-20260042867-A1 | ANTIBODY REPURPOSING | CD47, SSB, IGSF11 | HTR1A 584/4885NT5E 1154/4885TACR2 3277/4885 |
| US-20100267655-A1 | Glycosylated Warfarin Analogs and Uses Thereof | GPI, UGGT1, GALE | HTR1A 4865/4885NT5E 422/4885TACR2 2803/4885 |
| US-20070185063-A1 | Seven-membered ring nucleosides | NSUN2, NSUN3, HAVCR2 | HTR1A 3963/4885NT5E 158/4885TACR2 4573/4885 |
| US-20020002274-A1 | Process for the production of perbenzylated 1-0-glycosides | STT3B, MAN1B1, OSTC | HTR1A 3493/4885NT5E 4064/4885TACR2 4297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.